Home > Insider Trading > Filing (0001209191-12-014711)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411861	Mako Surgical Corp.	MAKO	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	201901148

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1433586	H Duncan Moffat	C/O Mako Surgical Corp. 2555 Davie Road Ft. Lauderdale FL 33317	Svp Of Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-02-28	6,300	$7.94	24,207	No	4	M	Direct
Common Stock	Disposition	2012-02-28	6,300	$40.00	17,907	No	4	S	Direct
Common Stock	Acquisiton	2012-02-29	12,800	$7.94	30,707	No	4	M	Direct
Common Stock	Disposition	2012-02-29	12,800	$40.02	17,907	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-02-28	6,300	$0.00	6,300	$7.94
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-02-29	12,800	$0.00	12,800	$7.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
68,488		2018-04-28	No	4	M	Direct
55,688		2018-04-28	No	4	M	Direct

Footnotes

The exercise and sales reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2011.
The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.05 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.12 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Vests and becomes exercisable ratably quarterly over four years commencing on the grant date.